1. Home
  2. RCON vs CUE Comparison

RCON vs CUE Comparison

Compare RCON & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recon Technology Ltd.

RCON

Recon Technology Ltd.

HOLD

Current Price

$1.41

Market Cap

46.9M

Sector

Energy

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.39

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCON
CUE
Founded
2007
2014
Country
China
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.9M
49.6M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
RCON
CUE
Price
$1.41
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
19.7K
2.1M
Earning Date
10-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,252,775.00
$7,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$0.23
52 Week High
$7.16
$1.54

Technical Indicators

Market Signals
Indicator
RCON
CUE
Relative Strength Index (RSI) 45.92 52.49
Support Level $1.36 $0.35
Resistance Level $1.60 $0.46
Average True Range (ATR) 0.13 0.05
MACD -0.02 0.01
Stochastic Oscillator 15.62 63.49

Price Performance

Historical Comparison
RCON
CUE

About RCON Recon Technology Ltd.

Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: